Early Detection of Neuron Loss in Alzheimer’s

Tau-C Biomarker

The Tau-C biomarker assay uses an antibody that specifically detects a fragment of tau produced by caspase-3. This assay is capable of detecting neuron loss already in the early stages of Alzheimer’s disease before the onset of symptoms.

After establishing the assay, we performed measurements in blood samples from individuals with brain injury, as brain injury is known to result in loss of neurons and release of fragments into the bloodstream.

Watch more videos about our biomarkers and the Protein Fingerprint on our YouTube channel!

Watch more videos about our biomarkers and the Protein Fingerprint on our YouTube channel!

Get in touch

Are you interested in exploring collaboration possibilities?
Enter your information in the form and a representative will contact you shortly.

+45 4452 5252 Contact us via email!

Your scientific area Select areaCardiologyDermatologyGastroenterologyHepatologyNephrologyNeurologyObesityPulmonologyRheumatologyMulti-organ/Other Your request Select requestGeneral inquiryBiomarkersLaboratorySomething else

First name Last name

Email Phone (optional) Your message (optional) Nordic Bioscience ApS and its non-profit partner, The Extracellular Matrix Pharmacology Congress, can contact me by email with news on research, events, products, and similar. I can always withdraw my consent at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.